Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver

Toxicological Sciences

Volumn 88, Issue 2, 2005, Pages 319-330

  Tilton, Susan C ^a,b   Gerwick, Lena G ^a   Hendricks, Jerry D ^a   Rosato, Caprice S ^a   Corley Smith, Graham ^a   Givan, Scott A ^a   Bailey, George S ^a,b   Bayne, Christopher J ^a   Williams, David E ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Aflatoxin B1; Gene regulation; Hepatocellular carcinoma; Oligonucleotide microarray; Rainbow trout

Indexed keywords

AFLATOXIN B1; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG METABOLISM; EXPERIMENTAL MODEL; FOOD CONTAMINATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; ISOLATED LIVER; LIPID METABOLISM; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MEDICAL RESEARCH; NONHUMAN; NUCLEOTIDE SEQUENCE; RAINBOW TROUT; UPREGULATION;

AFLATOXIN B1; ANIMALS; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCORHYNCHUS MYKISS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

ANIMALIA; ONCORHYNCHUS MYKISS; RODENTIA; SALMONIDAE;

EID: 28044467784     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfi309     Document Type: Article

References (52)

1. Akiba, J., Yano, H., Ogasawara, S., Higaki, K., and Kojiro, M. (2001). Expression and function of interleukin-8 in human hepatocellular carcinoma. Int. J. Oncol. 18, 257-264.
2. Bailey, G. S., Williams, D. E., and Hendricks, J. D. (1996). Fish models for environmental carcinogenesis: The rainbow trout. Environ. Health Perspect. 104(Suppl), 5-19.
3. Bjorge, L., Hakulinen, J., Vintermyr, O. K., Jarva, H., Jensen, T. S., Iversen, O. E., and Meri, S. (2005). Ascitic complement system in ovarian cancer. Br. J. Cancer 14, 895-905.
4. Borlak, J., Meier, T., Halter, R., Spanel, R., and Spanel-Borowski, K. (2005). Epidermal growth factor-induced hepatocellular carcinoma: Gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene 10, 1809-1819.
5. 1 hepatocarcinogenesis in rainbow trout. Cancer Res. 55, 57-62.
6. Breitkreutz, B. J., Jorgensen, P., Breitkreutz, A., and Tyers, M. (2001). AFM 4.0: A toolbox for DNA microarray analysis. Genome Biol. 2, software0001.1-0001.3.
7. Carruba, G., Cocciadiferro, L., Bellavia, V., Rizzo, S., Tsatsanis, C., Spandidos, D., Muti, P., Smith, C., Mehta, P., and Castagnetta, L. (2004). Intercellular communication and human hepatocellular carcinoma. Ann. NY Acad. Sci. 1028, 202-212.
8. Chen, C. J., Wang, L. Y., Lu, S. N., Wu, M. H., Lou, S. L., Zhang, Y. J., Wang, L. W., and Santella, R. M. (1996). Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24, 38-42.
9. Chen, W., Cai, M. Y., Wei, D. P., and Wang, X. (2005). Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma. World J. Gastroenterol. 11, 3297-3299.
10. Choi, J. K., Choi, J. Y., Kim, D. G., Choi, D. W., Kim, B. Y., Lee, K. H., Yeom Y. I., Yoo, H. S., Yoo, O. J., and Kim, S. (2004). Integrative analysis of multiple gene expression profiles applied to liver cancer study. FEBS Lett. 565, 93-100.
11. Ding, S., Gong, B. D., Yu, J., Gu, J., Zhang, H. Y., Shang, Z. B., Fei, Q., Wang, P., and Zhu, J. D. (2004). Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma. World J. Gastroenterol. 10, 3433-3440.
12. Egner, P., Wang, J., Zhu, Y., Zhang, B., Wu, Y., Zhang, Q., Qian, G. S., Kuang, Y. S., Gange, S. J., Jacobson, L. P., et al. (2001). Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci U.S.A. 98, 14601-14606.
13. El-Serag, H. B., and Mason, A. C. (1999). Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750.
14. Ficazzola, M. A., Fraiman, M., Gitlin, J., Woo, K., Melamed, J., Rubin, M. A., and Walden, P. D. (2001). Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22, 1271-1279.
15. Graveel, C. R., Jatkoe, T., Madore, S. J., Holt, A. L., and Farnham, P. J. (2001). Expression profiling of novel genes in hepatocellular carcinomas. Oncogene 20, 2704-2712.
16. Groopman, J. D., Scholl, P., and Wang, J. S. (1996). Epidemiology of human aflatoxin exposures and their relationship to human liver cancer. Can. J. Physiol. Pharmacol. 74, 203-209.
17. Hendricks, J. D., Meyers, T. R., and Shelton, D. W. (1984). Histological progression of hepatic neoplasia in rainbow trout (Salmo gairdneri). Monogr. Natl. Cancer Inst. 65, 321-336.
18. Jazaeri, A. A., Yee, C. J., Sotiriou, C., Brantley, K. R., Boyd, J., and Liu, E. T. (2002). Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J. Natl. Cancer Inst. 94, 990-1000.
19. Kakhlon, O., Gruenbaum, Y., and Cabantchik, Z. I. (2001). Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 97, 2863-2871.
20. Kanetaka, K., Sakamoto, M., Yamamoto, Y., Yamasaki, S., Lanza, F., Kanematsu, T., and Hirohashi, S. (2001). Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. J. Hepatol. 35, 637-642.
21. Krasnov, A., Koskinen, H., Pehkonen, P., Rexroad, C. E., III, Afanasyev, S., and Molsa, H. (2005a). Gene expression in the brain and kidney of rainbow trout in response to handling stress. BMC Genomics 6, 3.
22. Krasnov, A., Koskinen, H., Rexroad, C., Afanasyev, S., Molsa, H., and Oikari, A. (2005b). Transcriptome responses to carbon tetrachloride and pyrene in the kidney and liver of juvenile rainbow trout (Oncorhynchus mykiss). Aquatic Toxicol. 74, 70-81.
23. Lee, B. C., Hendricks, J. D., and Bailey, G. S. (1989). Iron resistance of hepatic lesions and nephroblastoma in rainbow trout (Salmo gairdneri) exposed to MNNG. Toxicol. Pathol. 17, 474-482.
24. Lee, B. C., Hendricks J. D., Bailey G. S. (1991). Toxicity of mycotoxins in the feed of fish. In Mycotoxins and Animal Feedstuff: Natural Occurrence, Toxicity and Control (J. E. Smith, Ed.), pp. 607-626. CRC Press, Boca Raton, FL.
25. Leong, W. I., and Lonnerdal, B. (2004). Hepcidin, the recently identified peptide that appears to regulate iron absorption. J. Nutr. 134, 1-4.
26. Li, F., and Stormo, G. D. (2001). Selection of optimal DNA oligos for gene expression arrays. Bioinformatics 17, 1067-1076.
27. Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J., and Hermeking, H. (2005). Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 65, 4218-4227.
28. Lu, Z. L., Luo, D. Z., and Wen, J. M. (2005). Expression and significance of tumor-related genes in HCC. World J. Gastroenterol. 11, 3850-3854.
29. 1-induced carcinogenesis by indole-3-carbinol in rat liver - Predicting the outcome using early biomarkers. Carcinogenesis 19, 1829-1836.
30. Meyer, K., Lee, J. S., Dyck, P. A., Cao, W. Q., Rao, M. S., Thorgeirsson, S. S., and Reddy, J. K. (2003). Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: Comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis 24, 975-984.
31. Moriwaki, H., Tajika, M., Miwa, Y., Kato, M., Yasuda, I., Shiratori, Y., Okuno, M., Kato, T., Ohnishi, H., and Muto, Y. (2000). Nutritional pharmacotherapy of chronic liver disease: From support of liver failure to prevention of liver cancer. J. Gastroenterol. 35(Suppl 12), 13-17.
32. Neo, S. Y., Leow, C. K., Vega, V. B., Long, P. M., Islam, A. F. M., Lai, P. B. S., Liu, E. T., and Ren, E. C. (2004). Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 39, 944-953.
33. 1-initiated hepatocarcinogenesis: Results from a 9000 animal tumor study. Carcinogenesis 20, 453-458.
34. Oka, R., Sasagawa, T., Ninomiya, I., Miwa, K., Tanii, H., and Saijoh, K. (2001). Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNAs in oesophageal carcinoma. Eur. J. Cancer 37, 1158-1165.
35. Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., and Nakamura, Y. (2001). Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61, 2129-2137.
36. Okihiro, M. S., and Hinton, D. E. (1999). Progression of hepatic neoplasia in medaka (Oryzias latipes) exposed to diethylnitrosamine. Carcinogenesis 20, 933-940.
37. Ouyang, G. L., Li, Q. F., Peng, X. X., Liu, Q. R., and Hong S. G. (2002). Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells. World J. Gastroenterol. 8, 1053-1058.
38. Ovejero, C., Cavard, C., Perianin, A., Hakvoort, T., Vermeulen, J., Godard, C., Fabre, M., Chafey, P., Suzuki, K., Romagnolo, B., et al. (2004). Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of β-catenin in the liver. Hepatology 40, 167-176.
39. Pitot, H. C., Dragan, Y. P., Teeguarden, J., Hsia, S., and Campbell, H. (1996). Quantitation of multistage carcinogenesis in rat liver. Toxicol. Pathol. 24, 119-128.
40. Poon, R. T. P., Lau, C. P. Y., Ho, J. W. Y., Yu, W. C., Fan, S. T., and Wong, J. (2003). Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin. Cancer Res. 9, 5339-5345.
41. Rise, M. L., Jones, S. R. M., Brown, G. D., von Schalburg, K. R., Davidson, W. S., and Koop, B. F. (2004). Microarray analyses identify molecular biomarkers of Atlantic salmon macrophage and hematopoietic kidney response to Piscirickettsia salmonis infection. Physiol. Genomics 20, 21-35.
42. Saal, H. L., Troein, C., Vallon-Christersson, J., Gruverger, S., Borg, A., and Peterson, C. (2002). BioArray Software Environment: A platform for comprehensive management and analysis of microarray data. Genome Biol. 3, software0003.1-0003.6.
43. Sauer, G., Windisch, J., Kurzeder, C., Heilmann, V., Kreienberg, R., and Deissler, H. (2003). Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of trans-endothelial invasion. Clin Cancer Res. 9, 6426-6431.
44. Schmitt-Graff, A., Ertelt, V., Allgaier, H. P., Koelbe, K., Olschewski, M., Nitschke, R., Bochaton-Piallat, M. L., Gabbiani, G., and Blum, H. E. (2003). Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology 38, 470-480.
45. Segal, E., Friedman, N., Kaminski, N., Regev, A., and Koller, D. (2005). From signatures to models: Understanding cancer using microarrays. Nat. Genet. 37, 538-545.
46. Sinnhuber, R. O., Wales, J. H., Ayres, J. L., Engebrecht, R. H., and Amend, D. L. (1968). Dietary factors and hepatoma in rainbow trout (Salmo gairdneri). 1. Aflatoxins in vegetable protein feedstuffs. J. Natl. Cancer Inst. 41, 711-718.
47. Stoner, G., Casto, B., Ralston, S., Roebuck, B., Pereira, C., and Bailey, G. (2002). Development of a multi-organ rat model for evaluating chemopreventive agents: Efficacy of indole-3-carbinol. Carcinogenesis 23, 265-272.
48. Su, B., Guan, M., Xia, J., and Lu, Y. (2003). Stimulation of lipocalin-type prostaglandin D synthase by retinoic acid coincides with inhibition of proliferation in human 3AO ovarian cancer cells. Cell Biol. Int. 27, 587-592.
49. Thirunavukkarasu, C., Singh, J. P. V., Selvendiran, K., and Sakthisekaran, D. (2001). Chemoprotective efficacy of selenium against N-nitrosodiethylamine-induced hepatoma in albino rats. Cell Biochem. Funct. 19, 265-271.
50. Tumminello, F. M., Leto, G., Pizzolanti, G., Candiloro, V., Crescimanno, M., Crosta, L., Flandina, C., Montalto, G., Soresi, M., Carroccio, A., et al. (1996). Cathepsin D, B and L circulating levels as prognostic markers of malignant progression. Anticancer Res. 16, 2315-2319.
51. Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., and Andrews, N. C. (2002). Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for anemia of chronic disease. Blood 100, 3776-3781.
52. Zheng, Q., Tang, Z. Y., Xue, Q., Shi, D. R., Song, H. Y., and Tang, H. B. (2000). Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J. Cancer Res. Clin. Oncol. 126, 641-646.